Reimagining DMTA as a connected network gives scientists the flexibility to act when needed, with context retained across every decision
Biopharma companies must break a recurring cycle of disconnected experiments, fragmented evidence, manual reconciliation, and repeated context reconstruction that slows learning across the scientific value chain.
Zifo calls this pattern the “DMTA doom loop”, a fundamental flaw in the Design-Make-Test-Analyse process. Scientific work is forced into a linear execution model rather than adapting to what the science requires. In its position paper, The Billion-Dollar Bottleneck: Why CMC Is Strangling the Biopharma Pipeline, Zifo argues that DMTA must evolve from a sequence of handoffs into a connected scientific network. Steps should be completed in any order, repeated when necessary, and supported by scientific context that travels with every sample, result, and decision.
To Download Paper, click here: https://zifo.com/cmc-million-dollar-bottleneck-biopharma/
When Every Experiment Begins with Reconstruction
Design-Make-Test-Analyse should operate as an interconnected learning cycle in which every result strengthens the organization’s understanding of relationships among materials, process conditions, equipment, analytical outcomes, product quality, and manufacturing performance.
In many CMC environments, however, evidence is scattered across scientific applications, instruments, spreadsheets, reports, PDFs, batch records, presentations, and individual expertise. Before scientists can interpret results or design the next experiment, they may need to locate data, reconcile sample identifiers, reconstruct experimental histories, and recover the reasoning behind earlier decisions.
The underlying problem is not simply fragmented data. It is the loss of scientific context and decision knowledge as information moves between systems, teams, and lifecycle stages. When results become separated from samples, methods, process conditions, and decision histories, the DMTA cycle may continue operationally without functioning effectively.
At the core of this breakdown is a failure of scientific user experience. The industry has often designed IT ecosystems around retrospective compliance and data architecture needs while making scientists’ daily work more difficult. Transforming CMC therefore requires enterprises to rethink scientific UX.
Faster Handoffs Do Not Necessarily Create Faster Learning
The paper cautions against merely digitizing existing workflows or adding another isolated application. Moving an inefficient process from paper or spreadsheets into a rigid digital template may only create a faster version of the same fragmentation, while encouraging scientists to develop workarounds outside governed systems.
Breaking the sequential model requires more than automating individual steps. It means reimagining DMTA as a connected, end-to-end scientific network in which:
- Scientists and engineers can move between steps as required.
- Relevant historical evidence is available during experimental design.
- Experimental intent and process context remain connected to samples.
- Results retain their relationships to methods, conditions, and materials.
- Analytical outputs can be interpreted alongside prior evidence.
- Decisions remain traceable to the supporting results and rationale.
- New knowledge becomes available to later experiments and downstream teams.
Together, these principles replace isolated systems and linear baton passes with connected scientific context and an agile DMTA network.
An Orchestration Layer Centered on the Scientist
Rather than proposing a monolithic platform, the paper calls for an orchestration layer connecting scientific activity across existing systems of record. This environment should adapt to scientific processes without replacing validated core systems. It should assemble the evidence and context needed for each task, enable information to be captured and reused across the DMTA network, and reduce the burden of navigating applications and manually reconstructing relationships.
Reimagining scientific UX also means replacing bloated, rigid workflow templates with small, modular, adaptable components built around critical capabilities. Scientists need a digital canvas that supports the immediate workflow while evolving as scientific demands change.
The paper also proposes governed Scientific Language Models (ScLM) grounded in proprietary scientific evidence. Within a connected and appropriately governed environment, these models could help organizations capture and interact with scientific knowledge while preserving traceability to the underlying evidence.
From Completing Experiments to Compounding Knowledge
A connected DMTA network shifts the objective from moving experiments through separate functional stages to expanding organizational knowledge with every experiment or test.
Achieving this requires collaboration across CMC, process development, analytical development, quality, manufacturing, IT, data, and scientific informatics. Organizations must also identify the scientific and operational choke points where reconnecting evidence and context can create meaningful value.
The paper recommends targeted integrations and lighthouse implementations rather than wholesale replacement of the existing technology estate. Organizations can begin with high-value workflows, demonstrate impact, and expand the model within brownfield environments.
Most importantly, scientists should not be forced through every stage when it is scientifically unnecessary. If contextual data already exists in the foundational layer, a researcher could move directly from Design to Analyse. Alternatively, they could move from Analysis into wet-lab execution because the relevant knowledge is already contextualized and accessible.
This fluidity breaks the delays created by the traditional linear value chain. It allows scientists to navigate the lifecycle according to the biological problem, preserves context across decisions, and turns each experiment from an isolated activity into a contribution to a compounding body of organizational knowledge.
To Download Paper, click here: https://zifo.com/cmc-million-dollar-bottleneck-biopharma/